Market: NMS |
Currency:
Address:
📈 NAMI Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for NAMI
| Date | Reported EPS |
|---|
| 2026-03-10 | - |
| 2025-12-22 | - |
| 2025-09-15 | - |
| 2025-06-24 | - |
| 2025-04-18 | - |
📰 Related News & Research
-
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview
April 4, 2026
AngioDynamics, Inc. Reports Q3 2026 Financial Results: Key H...
-
abrdn Global Dynamic Dividend Fund Enters Amended and Restated Sub-Placement Agent Agreement with ALPS Distributors and UBS Securities 49
April 2, 2026
abrdn Global Dynamic Dividend Fund Announces Launch of At-th...
-
Dynamix Corporation III 2025 Annual Report: AI, Energy, and Digital Infrastructure SPAC Business Strategy and Risk Factors
March 21, 2026
Dynamix Corporation III Annual Report: Key Details and Inves...
-
Dynamic Aerospace Systems Corp Files 8-K as Emerging Growth Company – SEC Filing Details for March 2026
March 20, 2026
Dynamic Aerospace Systems Announces Appointment of Permanent...
-
Biofrontera 2025 Company Overview: Ameluz Photodynamic Therapy, Product Pipeline, and U.S. Market Strategy
March 20, 2026
Biofrontera Inc. Files 2025 Annual Report: Key Highlights an...
-
Nomadar Corp. Assigns Naming Rights for JP Financial Arena Bahía de Cádiz in Landmark Sponsorship Agreement
March 16, 2026
NOMADAR CORP. – Assignment Agreement of Naming Rights & Shar...
-
VisDynamics Holdings Berhad Q1 2026 Financial Results: Revenue Decline, Losses, and Market Outlook
March 11, 2026
VisDynamics Holdings Berhad Q1 FY2026 Financial Report: In-D...
-
Biofrontera Reports Positive Phase 2b Results for Ameluz® Photodynamic Therapy in Moderate to Severe Acne Vulgaris 1
March 9, 2026
Biofrontera Inc. Reports Positive Phase 2b Results for Amelu...
-
Dynamix Corporation 2025 Annual Report: Proposed Business Combination with The Ether Machine, SPAC Strategy, Risk Factors, and Financial Overview
March 7, 2026
Dynamix Corporation 2025 Annual Report Analysis: Key Investo...
-
Grid Dynamics 2025 Annual Report: Enterprise AI Transformation, Services, Verticals, and Competitive Strengths
March 5, 2026
Grid Dynamics 2025 10-K: Detailed Investor Update Gr...
🔍 View more Reports
